chr22-28696960-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 5P and 1B. PM5PP3_ModeratePP5BS2_Supporting

The NM_007194.4(CHEK2):​c.1036C>T​(p.Arg346Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,612,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R346H) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000049 ( 0 hom. )

Consequence

CHEK2
NM_007194.4 missense

Scores

12
5
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:8U:18

Conservation

PhyloP100: 2.78

Publications

41 publications found
Variant links:
Genes affected
CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
CHEK2 Gene-Disease associations (from GenCC):
  • CHEK2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • Li-Fraumeni syndrome 2
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • acute myeloid leukemia
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary nonpolyposis colon cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr22-28696959-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 182431.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.912
PP5
Variant 22-28696960-G-A is Pathogenic according to our data. Variant chr22-28696960-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 142222.
BS2
High AC in GnomAdExome4 at 71 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007194.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHEK2
NM_007194.4
MANE Select
c.1036C>Tp.Arg346Cys
missense
Exon 10 of 15NP_009125.1O96017-1
CHEK2
NM_001005735.3
c.1165C>Tp.Arg389Cys
missense
Exon 11 of 16NP_001005735.1
CHEK2
NM_001438293.1
c.1129C>Tp.Arg377Cys
missense
Exon 11 of 16NP_001425222.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHEK2
ENST00000404276.6
TSL:1 MANE Select
c.1036C>Tp.Arg346Cys
missense
Exon 10 of 15ENSP00000385747.1O96017-1
CHEK2
ENST00000382580.6
TSL:1
c.1165C>Tp.Arg389Cys
missense
Exon 11 of 16ENSP00000372023.2O96017-9
CHEK2
ENST00000402731.6
TSL:1
c.835C>Tp.Arg279Cys
missense
Exon 8 of 13ENSP00000384835.2A0A7P0MUT5

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152032
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000517
AC:
13
AN:
251222
AF XY:
0.0000589
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000880
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000486
AC:
71
AN:
1460714
Hom.:
0
Cov.:
29
AF XY:
0.0000495
AC XY:
36
AN XY:
726734
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33466
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39676
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86220
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53354
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000549
AC:
61
AN:
1111032
Other (OTH)
AF:
0.0000828
AC:
5
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152032
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41402
American (AMR)
AF:
0.0000656
AC:
1
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10566
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.775
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000697
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000412
AC:
5

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
5
-
Familial cancer of breast (7)
2
4
-
not provided (6)
2
2
-
Hereditary cancer-predisposing syndrome (4)
1
1
-
Hereditary breast ovarian cancer syndrome (2)
-
2
-
not specified (2)
-
1
-
Breast and/or ovarian cancer (1)
-
1
-
Breast-ovarian cancer, familial, susceptibility to, 1 (1)
1
-
-
CHEK2-related cancer predisposition (1)
-
1
-
Familial cancer of breast;C0376358:Prostate cancer;C0585442:Bone osteosarcoma;C5882668:CHEK2-related cancer predisposition (1)
-
1
-
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.93
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Pathogenic
0.27
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.38
T
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.30
D
MetaRNN
Pathogenic
0.91
D
MetaSVM
Uncertain
-0.044
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
2.8
PrimateAI
Pathogenic
0.88
D
PROVEAN
Pathogenic
-7.5
D
REVEL
Pathogenic
0.78
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.98
MVP
0.78
MPC
0.18
ClinPred
0.99
D
GERP RS
3.5
Varity_R
0.92
gMVP
0.85
Mutation Taster
=21/79
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201206424; hg19: chr22-29092948; COSMIC: COSV60422106; COSMIC: COSV60422106; API